Stock Events

Stock Events

Celldex Therapeutics (CLDX) Q2 2018 Earnings

10MayConfirmed

Q3 2017

Q4 2017

Q1 2018

Q2 2018

-4.15

-3.07

-1.98

-0.9

Details

Expected EPS

-2.83

Actual EPS

-0.9

Surprise EPS

1.93

Surprise Percent

+68.2%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.9 per share for Q2 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.